📢 Exclusive on Gate Square — #PROVE Creative Contest# is Now Live!
CandyDrop × Succinct (PROVE) — Trade to share 200,000 PROVE 👉 https://www.gate.com/announcements/article/46469
Futures Lucky Draw Challenge: Guaranteed 1 PROVE Airdrop per User 👉 https://www.gate.com/announcements/article/46491
🎁 Endless creativity · Rewards keep coming — Post to share 300 PROVE!
📅 Event PeriodAugust 12, 2025, 04:00 – August 17, 2025, 16:00 UTC
📌 How to Participate
1.Publish original content on Gate Square related to PROVE or the above activities (minimum 100 words; any format: analysis, tutorial, creativ
AstraZeneca and Stone Pharmaceutical Group reach nearly $2 billion cardiovascular drug authorization protocol
On October 7th, Jin10 News reported that AstraZeneca and Chi-Med (01093.HK) have reached an exclusive licensing protocol to advance the development of a preclinical innovative small molecule lipoprotein(a) (Lp(a)) inhibitor to enhance the cardiovascular product pipeline. AstraZeneca said it will pay Chi-Med up to $1.92 billion in milestone and royalty payments and $100 million in upfront payment.